Mark Dransfield, MD
Disclosures: Consulting Fee-current-GlaxoSmithKline|Contracted Research-Current-Yungjin|Contracted Research-Current-PneumRx/BTG|Contracted Research-Current-Nuvaira|Contracted Research-Current-Novartis AG|Contracted Research-Current-GlaxoSmithKline|Contracted Research-Current-AstraZeneca|Contracted Research-Current-GALA|Contracted Research-Current-Boston Scientific Corporation|Contracted Research-Current-Boehringer Ingelheim Vetmedica GmbH|Consulting Fee-Current-Genentech, Inc.|Consulting Fee-Current-Mereo|Consulting Fee-Current-Boehringer Ingelheim Vetmedica GmbH|Consulting and contracted clinical trials -12/31/2018-Pulmonx|Consulting Fee-12/31/2018-AstraZeneca|Consulting Fee-12/31/2018-PneumRx/BTG|Consulting Fee-12/31/2018-Quark
No Bio Available.